Causal Inference and Shared Molecular Pathways in Crohn's Disease, Celiac Disease, and Ankylosing Spondylitis:

Ya Li1, Shihao Xu1, Mingzhu Zhang1

  • 1First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China.

Insights

This study found shared genetic links between Crohn's disease, celiac disease, and ankylosing spondylitis. Identifying common immune genes offers new therapeutic targets for these inflammatory conditions.

Area of Science:

  • Genetics and Immunology
  • Gastroenterology and Rheumatology

Background:

  • Crohn's disease (CD), celiac disease (CeD), and ankylosing spondylitis (AS) are distinct inflammatory conditions.
  • Understanding their shared underlying mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the causal and molecular overlap between CD, CeD, and AS.
  • To identify shared genetic factors and immune pathways implicated in these diseases.
  • To explore potential cross-disease therapeutic targets.

Main Methods:

  • Bidirectional Mendelian randomization was employed to assess causal relationships between disease pairs.
  • Transcriptomic analyses identified key upregulated genes across all three conditions.
  • Independent datasets and inflammatory cell models were used for validation.
  • Functional enrichment, regulatory network, and molecular docking analyses were performed.

Main Results:

  • Significant bidirectional causal associations were found between each pair of diseases (CD-CeD, CD-AS, CeD-AS).
  • Three hub genes (P2RY8, ITGAL, GPR65) were consistently upregulated across all conditions and validated.
  • These genes are implicated in immune signaling and mucosal inflammation.
  • Trichostatin A emerged as a potential therapeutic agent through network and docking analyses.

Conclusions:

  • Shared genetic and immune-related mechanisms underlie CD, CeD, and AS.
  • The identified hub genes represent potential therapeutic targets for cross-disease treatment strategies.
  • This research provides a foundation for novel therapeutic approaches targeting common pathways in these inflammatory diseases.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.3K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
392
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
237
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
426